Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma

Recently, N6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor microenvironment is involved in the regulation of tumorigenesis. In our research, the clinical data, including 374 tumor and 50 normal pa...

Full description

Bibliographic Details
Main Authors: Yangtao Xu, Xiaoqin He, Junjian Deng, Lin Xiong, Yue Li, Xiaoyu Zhang, Wenliang Chen, Xin Liu, Ximing Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.681745/full
_version_ 1818740410750599168
author Yangtao Xu
Xiaoqin He
Junjian Deng
Lin Xiong
Yue Li
Xiaoyu Zhang
Wenliang Chen
Xin Liu
Ximing Xu
author_facet Yangtao Xu
Xiaoqin He
Junjian Deng
Lin Xiong
Yue Li
Xiaoyu Zhang
Wenliang Chen
Xin Liu
Ximing Xu
author_sort Yangtao Xu
collection DOAJ
description Recently, N6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor microenvironment is involved in the regulation of tumorigenesis. In our research, the clinical data, including 374 tumor and 50 normal patients, were obtained from The Cancer Genome Atlas (TCGA). Then 19 m6A regulators were selected from other studies. Hepatocellular carcinoma (HCC) patients were clustered in cluster1/2, according to the consensus clustering for the m6A RNA regulators. We found that m6A regulators were upregulated in cluster1. The cluster1 was associated with higher programmed death ligand 1 (PD-L1) expression level, higher immunoscore, worse prognosis, and distinct immune cell infiltration compared with cluster2. Five risk signatures were identified, including YTH N6-methyladenosine RNA-binding protein 1, YTHDF2, heterogeneous nuclear ribonucleoprotein C, WT1-associated protein, and methyltransferase-like 3, based on univariate Cox and least absolute shrinkage and selection operator regression analysis. High-risk group and low-risk group HCC patients were selected based on the risk score. Similarly, the high-risk group was extremely associated with higher PD-L1 expression level, higher grade, and worse overall survival (OS). Also, cluster1 was mainly enriched in high-risk group. Receiver operating characteristic (ROC) and a nomogram were used to predict the ability and the probability of 3- and 5-year OS of HCC patients. The time-dependent ROC curve (AUC) reached 0.77, 0.67, and 0.68 at 1, 3, and 5 years in the training dataset. Also, AUC areas of 1, 3, and 5 years were 0.7, 0.63, and 0.55 in the validation dataset. The gene set enrichment analysis showed that MTOR signaling pathway and WNT signaling pathway were correlated with cluster1 and high-risk group. Collectively, the research showed that the m6A regulators were significantly associated with tumor immune microenvironment in HCC. Risk characteristics based on m6A regulators may predict prognosis in patients with HCC and provide a new therapeutic target for improving the efficacy of immunotherapy.
first_indexed 2024-12-18T01:40:17Z
format Article
id doaj.art-9e4eea21ae6d4a249e6cc3af9c771e25
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-18T01:40:17Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-9e4eea21ae6d4a249e6cc3af9c771e252022-12-21T21:25:20ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-06-01910.3389/fcell.2021.681745681745Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular CarcinomaYangtao Xu0Xiaoqin He1Junjian Deng2Lin Xiong3Yue Li4Xiaoyu Zhang5Wenliang Chen6Xin Liu7Ximing Xu8Cancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaRecently, N6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor microenvironment is involved in the regulation of tumorigenesis. In our research, the clinical data, including 374 tumor and 50 normal patients, were obtained from The Cancer Genome Atlas (TCGA). Then 19 m6A regulators were selected from other studies. Hepatocellular carcinoma (HCC) patients were clustered in cluster1/2, according to the consensus clustering for the m6A RNA regulators. We found that m6A regulators were upregulated in cluster1. The cluster1 was associated with higher programmed death ligand 1 (PD-L1) expression level, higher immunoscore, worse prognosis, and distinct immune cell infiltration compared with cluster2. Five risk signatures were identified, including YTH N6-methyladenosine RNA-binding protein 1, YTHDF2, heterogeneous nuclear ribonucleoprotein C, WT1-associated protein, and methyltransferase-like 3, based on univariate Cox and least absolute shrinkage and selection operator regression analysis. High-risk group and low-risk group HCC patients were selected based on the risk score. Similarly, the high-risk group was extremely associated with higher PD-L1 expression level, higher grade, and worse overall survival (OS). Also, cluster1 was mainly enriched in high-risk group. Receiver operating characteristic (ROC) and a nomogram were used to predict the ability and the probability of 3- and 5-year OS of HCC patients. The time-dependent ROC curve (AUC) reached 0.77, 0.67, and 0.68 at 1, 3, and 5 years in the training dataset. Also, AUC areas of 1, 3, and 5 years were 0.7, 0.63, and 0.55 in the validation dataset. The gene set enrichment analysis showed that MTOR signaling pathway and WNT signaling pathway were correlated with cluster1 and high-risk group. Collectively, the research showed that the m6A regulators were significantly associated with tumor immune microenvironment in HCC. Risk characteristics based on m6A regulators may predict prognosis in patients with HCC and provide a new therapeutic target for improving the efficacy of immunotherapy.https://www.frontiersin.org/articles/10.3389/fcell.2021.681745/fullhepatocellular carcinomam6A RNA methylationPD-L1tumor immune microenvironmentimmune infiltratesprognosis
spellingShingle Yangtao Xu
Xiaoqin He
Junjian Deng
Lin Xiong
Yue Li
Xiaoyu Zhang
Wenliang Chen
Xin Liu
Ximing Xu
Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
Frontiers in Cell and Developmental Biology
hepatocellular carcinoma
m6A RNA methylation
PD-L1
tumor immune microenvironment
immune infiltrates
prognosis
title Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
title_full Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
title_fullStr Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
title_full_unstemmed Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
title_short Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
title_sort comprehensive analysis of the immune infiltrates and pd l1 of m6a rna methylation regulators in hepatocellular carcinoma
topic hepatocellular carcinoma
m6A RNA methylation
PD-L1
tumor immune microenvironment
immune infiltrates
prognosis
url https://www.frontiersin.org/articles/10.3389/fcell.2021.681745/full
work_keys_str_mv AT yangtaoxu comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT xiaoqinhe comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT junjiandeng comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT linxiong comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT yueli comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT xiaoyuzhang comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT wenliangchen comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT xinliu comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma
AT ximingxu comprehensiveanalysisoftheimmuneinfiltratesandpdl1ofm6arnamethylationregulatorsinhepatocellularcarcinoma